Recurrent Endometrial Cancer

Also known as: Endometrial cancer recurrent / Cancer of endometrium recurrent / Ca endometrium recurrent / Endometrial carcinoma recurrent / Carcinoma endometrial recurrent

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00958Carboplatin0Terminated1
DB01229Paclitaxel0Terminated1
DB14922Tislelizumab0Terminated1
DB17146Abequolixron1Recruiting1
DB17450Albumin-stabilized nanoparticle (130 nm)1Withdrawn1
DB11666Buparlisib1Withdrawn1
DB00958Carboplatin1Recruiting1
DB01248Docetaxel1Recruiting1
DB11714Durvalumab1Terminated1
DB06186Ipilimumab1Recruiting1
DB04845Ixabepilone1Unknown Status1
DB01259Lapatinib1Unknown Status1
DB09078Lenvatinib1Completed1
DB15721Natural Killer Cell1Recruiting1
DB01229Paclitaxel1Completed1
DB01229Paclitaxel1Withdrawn1
DB09037Pembrolizumab1Recruiting1
DB00642Pemetrexed1Recruiting1
DB11771Tremelimumab1Terminated1
DB14707Cemiplimab1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Completed1
DB00331Metformin1 / 2Completed1
DB09074Olaparib1 / 2Completed1
DB11767Sarilumab1 / 2Recruiting1
DB06626Axitinib2Withdrawn1
DB08865Crizotinib2Recruiting1
DB14844Dordaviprone2Active Not Recruiting1
DB11714Durvalumab2Completed1
DB12167LY-30234142Completed1
DB09078Lenvatinib2Recruiting1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting1
DB09037Pembrolizumab2Withdrawn2
DB15036Sitravatinib2Withdrawn1
DB11771Tremelimumab2Completed1
DB00396ProgesteroneNot AvailableRecruiting1
DB00675TamoxifenNot AvailableRecruiting1